CytomX Therapeutics, Inc. (CTMX) Reports Full Year 2025 Earnings
...Estimate, Revenue Plunges 70.3% | XBIO: Xenetic Biosciences (XBIO) Reports Narrower Q4 Loss of $0.22/Share, Beating $0.52 Estimate by 57.7%…
...Estimate, Revenue Plunges 70.3% | XBIO: Xenetic Biosciences (XBIO) Reports Narrower Q4 Loss of $0.22/Share, Beating $0.52 Estimate by 57.7%…
$ANRO Earnings Per Share (GAAP) $-2.19 vs $-0.41 est. Revenue $0 vs $0 est. Loss Narrows. Alto Neuroscience, Inc. (NYSE:…
...then provide estimates for the second quarter. So starting with Financial Services. For the first quarter, our Financial Services team…
...today’s earnings release and Adobe’s SEC filings. On this call, we will discuss GAAP and non-GAAP financial measures. Our reported…
$TISI Team Inc (TISI) reported a Q4 2025 GAAP loss of $1.47 per share. No consensus estimate was available for…
...Inc (RPID) Reports Q4 Earnings | ALLO: Allogene Therapeutics (ALLO) Reports Q4 Loss of $0.28 Per Share, Flat Year-Over-Year |…
...reviewed by our editorial team. Related: Douglas Elliman Inc (DOUG) Reports Q4 Earnings | SUNS: Sunrise Realty Trust (SUNS) Q4…
$CULP Earnings Per Share (GAAP) $-0.27 estimate N/A Revenue $48.0M estimate N/A Loss widens sequentially: Culp, Inc (NYSE: CULP) reported…
...$0.08 per share loss reported in the year-ago quarter. For Q3 25, the household and personal products company reported a…
$JCAP Earnings Per Share (GAAP) $0.58 Revenue — estimate N/A Earnings hold steady. Jefferson Capital Inc reported Q4 2025 GAAP…